April 25, 2008. The FDA’s mission is to ensure that medical products are safe and effective. For LASIK, it is essential that we remember that safe alternatives are less expensive and readily available: glasses and contact lenses.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR Testimony on FDA Legislation Before the Subcommittee on Energy and Commerce
June 12, 2007. Every American relies on medical devices — whether they use band-aids, contact lenses, or pacemakers. Baby boomers increasingly rely on implanted medical devices, whether hips, heart valves, or wrinkle fillers.
Read More »NCHR Testimony on the Safety of Medical Products
March 9, 2007. The safety of medical products, especially prescription drugs and medical devices, has become an urgent issue for Congress.
Read More »NCHR Testimony at FDA on the NeuroStar TMS System for Major Depression
January 26, 2007. Depression is a serious and debilitating disease. The use of ineffective treatments can contribute to feelings of hopelessness, which in turn can worsen the symptoms and even result in suicide.
Read More »NCHR Joint Statement of Science, Public Health, and Consumer Groups
November 16, 2006. The Enhancing Drug Safety and Innovation Act is an important effort to respond to consumers’ increasing concerns about the inadequacy of current safeguards protecting the public from unreported risks of prescription drugs.
Read More »